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Intra-abdominal desmoplastic small round cell tumor (DSRCT) is a highly malignant tumor of uncertain histogenesis. Here 
we report a case of DSRCT involving the stomach, initially misdiagnosed as gastric cancer. A 12-year-old boy presented with 
upper abdominal pain developed 1 month prior. On gastroscopy, a 7-cm mass was noted involving the esophago-gastric 
junction to the fundus, and positron emission tomography showed multiple hot uptakes suggesting distant metastasis. 
Gastroscopic biopsy showed poorly differentiated malignant cells. We diagnosed as stage IV gastric cancer and treated with 
6 cycles of chemotherapy. Laparotomy revealed a huge gastric mass along with peritoneal disseminations. Palliative prox-
imal gastrectomy was performed. Pathological examination revealed transmural involvement of DSRCT, and 
t(11;22)(p12;q12) was demonstrated on fluorescence in situ hybridization test. The chemotherapeutic regimen was changed 
and the patient underwent 8 additional cycles of post-operative chemotherapy. The patient is now alive and the residual tu-
mor shows no significant changes after chemotherapy.
Key Words: Stomach, Desmoplastic small round cell tumor, Children
INTRODUCTION
Intraabdominal desmoplastic small round cell tumors 
(DSRCT) are rare, but aggressive mesenchymal malig-
nancies of uncertain origin [1]. This tumor typically occurs 
during adolescence and young adult life in males. It usu-
ally presents with symptoms of abdominal pain, weight 
loss, nausea, vomiting, and a palpable abdominal mass [1]. 
Findings at laparotomy frequently include peritoneal dis-
semination of uncertain origin, ascites, and occasionally 
visceral implantations forming a mass [1]. Since primary 
gastrointestinal (GI) malignancies are rare in children, the 
mass-forming DSRCT mimicking a GI tract tumor is diffi-
cult to diagnose before a laparotomy. Here we report a case 
of DSRCT involving the stomach that was initially mis-
diagnosed as a gastric cancer. 
CASE REPORT
A 12-year-old boy presented with epigastric pain that 
developed 1 month ago. An episode of syncope with hem-Stomach and desmoplastic small round cell tumor
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Fig. 1. Pre-operative gastroscopy shows huge mass located at the 
esophago-gastric junction.
Fig. 2. Multiple, enlarged (A) retropancreatic and (B) aortocaval, retrocaval lymph nodes are seen on abdominal computed tomography scan
(line-indicated).
Fig. 3. Positron emission tomography scan. Numerous hot uptakes 
are seen at left supraclavicular area, retroperitoneum, pelvis, and 
pleura, thus suggesting metastases.
atochezia was reported 2-week ago. The family and medi-
cal history were unremarkable. On physical examination, 
the patient appeared pale with no other significant find-
ings noted. Laboratory tests revealed hemoglobin of 7.0 
g/dL and no other abnormal findings. On gastroscopy, a 
7-cm mass was noted at the esophago-gastric junction and 
posterior wall of the cardia. The overlying mucosa and the 
bridging folds appeared normal, thus suggesting a sub-
mucosal tumor (Fig. 1). Abdominal computed tomog-
raphy (CT) showed a large gastric mass with multiple en-
larged retropancreatic and aortocaval lymph nodes (Fig. 
2). Positron emission tomography (PET) showed multiple 
uptake suggesting metastases to the left supraclavicular, 
right pleural, pelvic and retroperitoneal lymph nodes (Fig. 
3). The gastroscopic biopsy specimen showed a poorly dif-
ferentiated carcinoma.
Based on the findings of malignant mass on gastroscopy 
and pathological examination, metastatic lesions on CT 
and PET, we diagnosed as the stage IV gastric cancer. The 
patient underwent 6 cycles of neo-adjuvant chemotherapy 
with docetaxel and cisplatin. Evaluation after the chemo-Suk-Bae Moon, et al.
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therapy showed a slightly regressed gastric mass; how-
ever, the retroperitoneal metastases progressed. On lapa-
rotomy, a huge mass from the lesser curvature of the stom-
ach invading the gastrohepatic ligament was noted along 
with numerous peritoneal implantations. The tail of pan-
creas was palpated hardly, suggesting invasion from the 
retropancreatic metastases. Palliative proximal gas-
trectomy with esophago-gastric anastomosis was per-
formed, and the final pathological examination revealed 
transmural involvement of DSRCT (Fig. 4). A reciprocal 
translocation t(11;22)(p13;q12) was demonstrated on fluo-
rescent in situ hybridization test. The post-operative che-
motherapeutic regimen was changed to CCG 7881B: cyclo-
phosphamide, doxorubicin, and vincristine. The patient 
underwent 8 cycles of CCG 7881B, but the residual disease 
showed no changes. 
DISCUSSION
Intraabdominal DSRCT has rarely been reported in 
adolescents and young adult males, and few long-term 
survivors have been described and the survival prognosis 
following the diagnosis is an average of 23 months [2]. Due 
to the highly aggressive nature and diffuse spread of the 
DSRCT, systemic chemotherapy has been used as the ini-
tial treatment along with debulking surgery. Lal et al. [3] 
achieved an over 90% reduction of the tumor bulk in 71% 
of their patients and demonstrated a significant survival 
benefit, thus suggesting the benefit of aggressive surgical 
resection. By contrast, Livaditi et al. [4] reported that even 
radical surgical efforts were palliative with a dismal out-
Fig. 4. (A) Sharply demarcated aggregates of small round cells are 
seen within the dense fibrous stroma (H&E, ×200), and (B) tumor 
cells are positive for desmin (dot-like expression, ×200) and (C) 
cytokeratin (×200) in immunohistochemical staining.Stomach and desmoplastic small round cell tumor
thesurgery.or.kr S83
come despite all therapeutic modalities. It was impossible 
in the case reported here to achieve a large volume reduc-
tion at surgery because of the massive retroperitoneal 
involvement. Whether it is worth sacrificing major organs 
such as the liver and pancreas for cytoreductive surgery in 
patients with DSRCT is debatable. 
Primary gastric cancer, although rare, has been reported 
sporadically in children and the reported incidence is 
about 0.1% [5]. However, DSRCT of the stomach is ex-
tremely rare; only one case has been previously reported 
in children [5]. The rarity of this condition along with the 
inconspicuous pathology led us to misdiagnose as stage 
IV gastric cancer before surgery. We suggest that, when 
poorly differentiated malignancies of the stomach are be-
ing considered, DSRCT should be in the differential diag-
nosis, especially among adolescent and young adult 
males. Moreover, since DSRCT can form a mass along the 
whole GI tract, thus mimicking a primary GI tract tumor, 
DSRCT should be included in the differential diagnosis of 
primary GI tract tumors in children.
DSRCT typically display clusters or nests of small 
round cells lying in a hypocellular, desmoplastic, collage-
nous stroma and this is a helpful diagnostic feature. In im-
munohistochemical staining, the DSRCT is usually pos-
itive for desmin (dot-like expression) and cytokeratin [6]. 
The case reported here satisfies the typical pathological 
and immunohistochemical staining profiles and we could 
make the diagnosis of DSRCT, which was impossible be-
fore laparotomy.
The reciprocal translocation t(11;22)(p13;q12) is unique 
to the DSRCT and confirms the diagnosis [7]. The trans-
location fuses two specific genes: the Ewing sarcoma gene 
(found in Ewing’s sarcoma) and the Wilms tumor 1 gene 
(found in Wilms’ tumor), and the resultant chimera pro-
tein is thought to act as a transcriptional regulator [8]. This 
transcriptional factor is known to regulate the expression 
of specific target genes, and the dysregulated expression 
of the target genes is related to the invasiveness of the 
DSRCT [9]. Recently, connective tissue growth factor 
(CCN2) that is highly expressed in DSRCT, has been found 
to regulate the tumor cell growth, matrigenesis, and an-
giogenesis of this tumor [10]. As conventional multimodal 
treatments fail to improve survival, future treatment 
should include specific targeted treatment focusing on 
these cellular regulatory mechanisms.   
“Initially responsive but soon refractory to the treat-
ment and rapidly progressive” depicts the clinical behav-
ior of the DSRCT [4]. The case reported here showed an ini-
tial treatment-response of the gastric mass after the neo- 
adjuvant chemotherapy; however, the residual tumors re-
mained nearly unchanged postoperatively after adjuvant 
chemotherapy with CCG 7881B. The tumors are likely 
now in a refractory phase and will soon show rapid dis-
ease progression, eventually leading to the death of this 
patient. 
In summary, a patient with intraabdominal DSRCT 
mimicking a gastric cancer is presented in this report. The 
diagnosis was determined after laparotomy. The diffuse 
intraabdominal spread made it impossible to extirpate the 
lesions completely. Although post-operative chemo-
therapy was provided and the patient is now alive with re-
sidual disease, the prognosis is dismal. 
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